Welcome : Guest

STEM CELLS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Stem Cell Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 66 companies including many key and niche players such as -

Athersys, Inc.
Apceth GmbH & Co.KG
AVIVA BioSciences Corporation
BioE, Inc.
Bone Therapeutics SA

Click here to request a full list of companies covered in the report...

Code: MCP-6142
Price: $4950
Companies: 66
Pages: 229
Date: May 2017
Market Data Tables: 25
  Status: * New Report



TABLE OF CONTENTS


  STEM CELLS (Complete Report) Pages : 229   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries.....II-11$100
   Select Approved Stem Cell Products.....II-21$100
   Stem Cells Bypass Use of Animal Models in Drug Discovery Programs.....II-3
Trends Related to Stem Cell Clinical Trials.....II-3
1$100
   Table 1: Clinical Tests by Type: Allogenic Vs. Autologous (In %) (includes corresponding Graph/Chart).....II-4

Table 2: Stem Cells Clinical Trials by Country: 2008-2014 (includes corresponding Graph/Chart).....II-4
1$350
   Select Stem Cell Pipeline Analysis.....II-51$100
   Current & Future Analysis.....II-6
Stem Cell Research Funding Policies across the World.....II-6
1$100
   Japan and US – Pioneering Induced Pluripotent Stem Cell (iPSC) Research.....II-71$100
   Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical
  Applications.....II-8
1$100
   Dental Mesenchymal Stem Cells – Emergence of a Niche Market.....II-91$100
   For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research.....II-10
Unproven Therapies Do Online Rounds as Effective Treatment Options – A Cause of
  Concern.....II-10
1$100
   Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells.....II-11
Embryonic Stem Cell Gene Nanog Found to Reverse Aging.....II-11
1$100
   Canadian and Dutch Scientists Finds the “Genetic Switch” to Increase Stem Cell Volume
  from Cord Blood.....II-12
1$100
   The Boston Program Pioneers Cell-based Personalized Diabetes Treatment.....II-13
iPSCs Provide Valuable Source for Retinal Transplants and Other Applications.....II-13
Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac
  Disorders.....II-13
1$100
   Stem Cell Therapy – An Alternative to Orthopedic Surgery in Younger Patients?.....II-141$100
   Application of Plant Stem Cells in Cosmetic Treatments – Myths Busted.....II-151$100
   Adverse Reactions of Stem Cell-Face Lift Therapy.....II-16
Stem Cell-Breast Enhancement.....II-16
Other Innovations Using Stem Cells.....II-16
2$200
   New Stem Cell Software & Products.....II-181$100
   Stem Cell Research.....II-19
Stem Cells – Description.....II-19
Types of Stem Cells.....II-19
Embryonic Stem Cells.....II-19
mES and hES.....II-19
1$100
   R-NSCs.....II-20
Adult Stem Cells.....II-20
Hematopoietic Stem Cells.....II-20
1$100
   Mesenchymal Stem Cells.....II-21
Umbilical Cord Stem Cells.....II-21
1$100
   Neuronal Stem Cells.....II-22
Dental Stem Cells.....II-22
Pluripotent Adult Stem Cells.....II-22
Other Key Cell Types.....II-22
1$100
   The Stem Cell Line – Cell Division.....II-23
Stem Cells – Properties.....II-23
Ability to Renew on its Own.....II-23
Potency.....II-23
Definitions of Various Potencies.....II-23
1$100
   Identification of Stem Cells.....II-24
Stem Cells – Applications.....II-24
1$100
   History of Stem Cells.....II-25
Stem Cells – Services and Products.....II-25
Significance of Stem Cell Products/Services.....II-25
1$100
   Minerva Biotechnologies Launches AlphaSTEM™, a Naïve Stem Cell Culture System.....II-26
Takara Bio Launches Human iPSC-Derived Beta Cells for Drug Screening and Diabetes
  Research.....II-26
RenovaCare Develops New Stem Cell Device for Burn Injuries.....II-26
Mesoblast Launches the World’s First Off-The-Shelf Stem Cell Treatment.....II-26
Mesoblast Licensee launches first stem cell product in Japan.....II-26
Stempeutics Research Receives Approval for India's First Stem Cell Based Drug.....II-26
1$100
   Nature Cell Commences Phase I and II Clinical Trials of ‘ASTROSTEM’ in the US for
  Treating Alzheimer.....II-27
Tisch MS Research Center Commences Phase II Stem Cell Clinical Trial for MS.....II-27
Canadian Clinical Trial to Test Neural Stem Cells in Patients with Spinal Cord
  Injuries.....II-27
Neuralstem’s ALS Stem Cell Therapy Exhibits Safety and Efficacy in Early Clinical
  Trials.....II-27
The University of Michigan Commences Large Scale Clinical Trials for ALS
  Therapy.....II-27
1$100
   Bionomics Receives FDA Approval for Phase I Clinical Trial in Cancer Patients.....II-28
AHSCT Shows Reduced Brain Lesions in Phase 2 Clinical Trial.....II-28
Neuralstem’s Neural Stem Cell Treatment Meets Primary Safety Endpoints in Phase 2
  Trials.....II-28
1$100
   GE Health Acquires Biosafe.....II-29
Human Longevity Acquires Lifebank.....II-29
AbbVie to Acquire Stemcentrx and Its Lead Asset Rova-T.....II-29
Thorn Medical Acquires Okyanos Holding Company.....II-29
Bio-Techne Corporation Acquires Zephyrus Biosciences.....II-29
Astellas Pharma to Complete Acquisition of Ocata Therapeutics.....II-29
Bayer Launches Stem Cell Therapy Company BlueRock Therapeutics.....II-29
1$100
   apceth Signs License Option Agreement with Cynata Therapeutics Ltd.....II-30
StemBioSys Announces European Distribution Agreement with Cellaviva AB of
  Sweden.....II-30
Fujifilm Holdings Acquires Cellular Dynamics International.....II-30
American CryoStem Corporation Acquires Biolife Cell Bank.....II-30
NeoStem Announces Plans to Change Name to Caladrius Biosciences Reflecting
  Transformation into Immunotherapy Company.....II-30
ESI BIO Announces Alliance Agreement with Pivotal Scientific Ltd for Distribution of
  Stem Cell Products.....II-30
1$100
   TiGenix and Lonza Signs Agreement for the Manufacture of Stem Cell-based
  Treatment.....II-31
AlloSource Receives Patent for AlloStem® Cellular Bone Allograft.....II-31
1$100
   Athersys, Inc. (USA).....II-32
Apceth GmbH & Co.KG (Germany).....II-32
AVIVA BioSciences Corporation (USA).....II-32
1$100
   BioE, Inc. (USA).....II-33
Bone Therapeutics SA (Belgium).....II-33
1$100
   Cesca Therapeutics, Inc. (USA).....II-34
Cryo-Cell International, Inc. (USA).....II-34
Cytori Therapeutics, Inc. (USA).....II-34
1$100
   ESI BIO, a Division of BioTime Inc. (USA).....II-351$100
   Gamida Cell Ltd. (Israel).....II-36
Holostem Terapie Avanzate (Italy).....II-36
International Stem Cell Corporation (USA).....II-36
1$100
   Kangstem Biotech., Ltd. (Korea).....II-37
Lonza Group Ltd (Switzerland).....II-37
Mesoblast Ltd. (Australia).....II-37
1$100
   Neuralstem, Inc. (USA).....II-38
Nuvasive, Inc. (USA).....II-38
1$100
   Osiris Therapeutics, Inc. (USA).....II-39
OncoMed Pharmaceuticals, Inc (USA).....II-39
1$100
   PROMETHERA Biosciences S.A.N.V (Belgium).....II-40
Reliance Life Sciences (India).....II-40
ReNeuron Group Plc. (UK).....II-40
1$100
   STEMCELL Technologies, Inc. (Canada).....II-41
Stemedica Cell Technologies, Inc (USA).....II-41
Stempeutics Research Pvt. Ltd. (India).....II-41
1$100
   Takara Bio USA Inc (USA).....II-42
TiGenix NV (Belgium).....II-42
U.S Stem Cell, Inc. (USA).....II-42
1$100
   ViaCord, LLC (USA).....II-431$100
   Table 3: World Recent Past, Current and Future Analysis for Stem Cell Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-441$350
   Table 4: World 8-Year Perspective for Stem Cell Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2017 and 2024 (includes corresponding Graph/Chart).....II-451$350
   A. Market Analysis.....III-1
Hemacord – The Only FDA-Approved Cord Blood- Derived Hematopoietic Progenitor
  Cells.....III-1
FDA to Implement Strict Regulations on Unapproved Stem Cell Treatment.....III-1
1$75
   Consumer Watchdog against Embryonic- Stem Cell Patents.....III-21$75
   Clinical Trials.....III-32$150
   Strategic Corporate Developments.....III-51$75
   Product Launches.....III-61$75
   Select Key Players.....III-77$525
   B. Market Analytics.....III-14
Table 5: The US Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-14
1$200
   A. Market Analysis.....III-15
Stem Cell Initiatives.....III-15
1$75
   Clinical Trials.....III-16
Select Key Player.....III-16
1$75
   B. Market Analytics.....III-17
Table 6: Canadian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-17
1$200
   A. Market Analysis.....III-18
Multinational Companies Leverage Japan’s Relaxed Regulatory Regime for Furthering
  Stem Cell Research.....III-18
Strategic Corporate Development.....III-18
1$75
   B. Market Analytics.....III-19
Table 7: Japanese Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-19
1$200
   A. Market Analysis.....III-20
Strategic Corporate Developments.....III-20
Select Key Players.....III-20
4$300
   B. Market Analytics.....III-24
Table 8: European Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country: France, Germany, Italy, UK, Spain, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-24
1$200
   Table 9: European 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of European Markets for Years 2017 & 2024 (includes corresponding Graph/Chart).....III-251$200
   Market Analysis.....III-26
Table 10: French Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-26
1$200
   Market Analysis.....III-27
Table 11: German Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-27
1$200
   Market Analysis.....III-28
Table 12: Italian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-28
1$200
   A. Market Analysis.....III-29
Stem Cell Storage Venture by NHS Trust Aims to Improve Public Donation.....III-29
UK Scientists Use Adult-Stem Cells for Treating Multiple Sclerosis.....III-29
1$75
   B. Market Analytics.....III-30
Table 13: The UK Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-30
1$200
   Market Analysis.....III-31
Table 14: Spanish Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-31
1$200
   A. Market Analysis.....III-32
Stem Cell Research Gains Momentum in Russia.....III-32
B. Market Analytics.....III-32
Table 15: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-32
1$200
   A. Market Analysis.....III-33
India & China: Potential-Laden Populous Markets for Stem Cell Research.....III-33
1$75
   Table 16: Ten Largest Populated Countries Worldwide (July 2015): Total Population (in Millions) by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart).....III-341$200
   Product Launches.....III-35
Strategic Corporate Development.....III-35
Select Key Players.....III-35
3$225
   B. Market Analytics.....III-38
Table 17: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-38
1$200
   Table 18: Asia-Pacific 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2017 & 2024 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
Chinese Stem Cell Market Set to Register Robust Growth.....III-40
Chinese Market for Stem Cell Research: Lack of Technological Innovation Restrains
  Governmental Initiatives.....III-40
4$300
   B. Market Analytics.....III-44
Table 19: Chinese Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-44
1$200
   A. Market Analysis.....III-45
Steady Strides in India’s Stem Cells Market.....III-45
1$75
   Regulatory Guidelines Promote Ethical Harvesting of Stem Cells.....III-46
Indian Researchers use Hair Follicle and Skin Stem Cells for Burn and Vitiligo
  Patients.....III-46
1$75
   Stem Cell Research—Imperative for Australia.....III-47
Korean Scientists Develop Technique to Use Stem Cells for Treating Macular
  Degeneration.....III-47
1$75
   Select Stem Cell Products Approved in the Korean Market.....III-48
B. Market Analytics.....III-48
Table 20: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-48
1$200
   Market Analysis.....III-49
Table 21: Latin American Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - Brazil, and Rest of Latin America Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-49
1$200
   Table 22: Latin American 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin American Markets for Years 2017 & 2024 (includes corresponding Graph/Chart).....III-501$200
   Market Analysis.....III-51
Table 23: Brazilian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-51
1$200
   Market Analysis.....III-52
Table 24: Rest of Latin America Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-52
1$200
   A. Market Analysis.....III-53
Select Key Player.....III-53
1$75
   B. Market Analytics.....III-54
Table 25: Rest of World Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-54
1$200
  
Total Companies Profiled: 66 (including Divisions/Subsidiaries - 69)

Region/Country Players

The United States 39 Canada 1 Japan 1 Europe 13 Germany 2 The United Kingdom 5 Italy 1 Rest of Europe 5 Asia-Pacific (Excluding Japan) 12 Middle East 1 Latin America 1
Click here to request a full table of contents and more details on this project.